<DOC>
	<DOCNO>NCT00683943</DOCNO>
	<brief_summary>This study evaluate side effect tolerability drug lithium patient spinocerebellar ataxia type I ( SCA1 ) inherit disorder cause loss nerve cell part brain . Symptoms include ataxia ( difficulty walk ) loss muscle coordination strength . Recent study suggest lithium may helpful treat SCA1 symptom . People 18 65 year age SCA1 difficulty walk difficulty walk well tremor , hand incoordination speech problem , may eligible study . Participation require three hospital admission NIH Clinical Center one outpatient visit . Participants undergo follow test procedure : Admission 1 ( 2-6 week ) - Medical history , physical examination , blood urine test , electrocardiogram . - Evaluation SCA1 symptom ( balance , walk , dexterity , tremor , memory , mood concentration ) . - Monitoring liquid intake output ( urine ) weight change . - Lithium treatment Start treatment remain hospital blood level drug stabilize ; continue treatment home hospital discharge . Admission 2 ( 2-4 day , 4 week hospital discharge ) . - Repeat procedure do first admission . - Continue lithium hospital home discharge , local physician check laboratory value need . Admission 3 ( 2-4 day , 8 week Admission 2 ) . - Repeat procedure do admission . - Stop lithium . Outpatient Visit ( 4 week Admission 3 ) - Evaluation SCA1 symptom . - Blood urine test .</brief_summary>
	<brief_title>Lithium Treatment Patients With Spinocerebellar Ataxia Type I</brief_title>
	<detailed_description>Objective Evaluation tolerability safety lithium SCA1 patient . Study Population A total 10 molecularly diagnose SCA1 patient divide two group . One group would compose 5 patient gait difficulty 5 patient gait difficulty tremor , hand incoordination speech difficulty . Design Patients admit NIH Clinical Center initiation titration Lithium high therapeutic level currently accept treatment Bipolar affective disorder achieve ( 1.0-1.2 mmol/L ) maximum tolerate dose . During admission , neurological evaluation , ataxia tremor evaluation , timed-up-and-go testing , quality life assessment , questionnaires evaluate sleep , balance confidence depression , memory testing , alertness assessment quantitative balance/sway evaluation . Parameters side effect profile assess baseline , 1 month ( plus minus 5 day ) 3 month ( plus minus 5 day ) achievement therapeutic level . They also exit evaluation one month ( plus minus 5 day ) discontinuation Lithium also NIH . For baseline evaluation titration , patient admit NIH 4 week plus minus 2 week . Evaluation 1 month ( plus minus 5 day ) 3 month ( plus minus 5 day ) Outcome Measures Primary Outcomes 1 . Incidence side effect 2 . Side effect profile Secondary Outcomes 1 . Timed-up-and-go test 2 . ICARS score 3 . SARA score 4 . Modified Falls Efficacy Scale 5 . Quantitative Sway/Balance assessment 6 . Tremor Rating Scale : - Part A Tremor location/severity rating - Part B Handwriting drawing - Part C Functional disability result tremor 7 . Questionnaires related sleep , depression ( Beck Depression Inventory ) ( BDI ) , alertness ( Computerized Continuous Performing Tasks ) memory ( Mini Mental State Examination ) 8 . Dexterity evaluation At-Home Testing Program device</detailed_description>
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Spinocerebellar Ataxias</mesh_term>
	<mesh_term>Spinocerebellar Degenerations</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>INCLUSION CRITERIA : 1865 year age Molecularly diagnose SCA1 Gait disturbance gait disturbance tremor and/or hand incoordination and/or speech difficulty . Women childbearing age agree use contraceptive method duration study . EXCLUSION CRITERIA : Children Pregnant nursing woman Anyone lowsodium diet Cognitively impaired individual Schizophrenics Family history thyroid diseases Patients medical condition affect Lithium diabetes mellitus , difficulty urinating , infection ( severe occur fever , prolong sweating , diarrhea , vomit ) , kidney disease , epilepsy , thyroid disease , heart disease , pulmonary disease , bipolar affective disorder , cardiac arrhythmia , diabetes insipidus , Parkinson disease , psoriasis leukemia . Anyone take follow medication : diuretic , nonsteroidal antiinflammatory agent , methyldopa , tetracycline , antipsychotic , neuromuscular block agent , digoxin , phenytoin , acetazolamide , calcium iodide , iodinate glycerol , potassium iodide , calcium channel blocker and/or metronidazole . Patients medication may enrol lithium level follow closely . If level consistently maintain , subject may remain study . Age great 65 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 27, 2014</verification_date>
	<keyword>Spinocerebellar Ataxia</keyword>
	<keyword>Lithium</keyword>
</DOC>